Vertex Pharmaceuticals | VRTX - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 521.8B 77.2B 2026-10
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 22.44B 10.57B 2026-10
Amgen USD 195.44B 5.55B 2026-06
Arrowhead Research USD 11.5B 2.72B 2026-06
Biogen USD 35.56B 2.19B 2026-10
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 124.51B 2.96B 2026-10
Gilead Sciences USD 206.51B 21.7B 2026-10
Incyte USD 26.22B 1.63B 2026-10
Insmed USD 16.56B 8.37B 2026-10
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 607B 46.61B 2026-10
Merck USD 370.6B 12.1B 2026-10
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 266.01B 25.42B 2026-10
Pfizer USD 138.44B 15.37B 2026-06
PTC Therapeutics USD 4.94B 1.86B 2026-10
Regeneron Pharmaceuticals USD 100.79B 35.42B 2026-10
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 99.83B 8.68B 2026-10
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06